fibrinogen has been researched along with Parkinson Disease in 13 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (7.69) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 8 (61.54) | 24.3611 |
| 2020's | 4 (30.77) | 2.80 |
| Authors | Studies |
|---|---|
| Argüero-Sánchez, R; Bernal-Conde, LD; Callea, F; Garrido-Figueroa, JF; Guerra-Crespo, M; Hernández-López, A; Hiriart, M; Martínez-Becerril, HA; Padilla-Godínez, FJ; Ramos-Acevedo, R | 1 |
| Alladi, PA; Dharmappa, A; Hegde, S; Kamble, N; Naskar, A; Pal, PK; Philip, M; Saini, J; Sandhya, K; Stezin, A; Tatu, U; Yadav, R | 1 |
| Andresen, TL; Aznar, S; Bech, S; Blaabjerg, M; Bode, M; Brudek, T; Danielsen, EH; DellaValle, B; Folke, J; Hejl, AM; Hempel, C; Løkkegaard, A; Møller, M; Olsen, JV; Pakkenberg, B; Rungby, J; Rydbirk, R; Salvesen, L; Starhof, CC; Winge, K; Østergaard, O | 1 |
| Cao, P; Chan, L; Chan, P; Chang, Z; Chao, Y; Chen, Z; Deng, B; Lyu, Q; Pan, Y; Que, R; Tan, EK; Wang, Q; Wang, T; Wang, Y; Xu, L; Yang, W; Yenari, MA; Yuan, F; Zhu, S | 1 |
| Burnouf, T; Chang, HM; Chou, ML; Devedjian, JC; Devos, D; Gouel, F; Jonneaux, A; Laloux, C; Lin, LT; Renn, TY; Timmerman, K; Wu, JW | 1 |
| Cho, HJ; Chung, SW; Kim, YD; Song, IU | 1 |
| Gentleman, SM; Griffin, WS; Kalaitzakis, ME; Pearce, RK; Pey, P | 1 |
| Cui, L; Li, J; Li, P; Liu, B; Lu, W; Rong, X; Wan, X; Wang, L; Wang, X; Zhu, L | 1 |
| Blanchette, P; Curb, JD; Grandinetti, A; Grove, JS; Rodriguez, BI; Ross, GW; Wong, KT; Yee, M | 1 |
| Biggs, ML; Boudreau, R; Checkoway, H; Jain, S; Longstreth, WT; Newman, AB; Strotmeyer, ES; Thacker, EL; Ton, TG | 1 |
| Adler, CH; Beach, TG; Kokjohn, TA; Maarouf, CL; Roher, AE; Sabbagh, MN; Shill, HA; Walker, DG; Wu, T | 1 |
| Alberio, T; Cecconi, D; Comi, C; Fasano, M; Lopiano, L; Olgiati, S; Pippione, AC; Zibetti, M | 1 |
| Göltner, E; Spuler, O; Ströder, J | 1 |
1 review(s) available for fibrinogen and Parkinson Disease
| Article | Year |
|---|---|
Protein Misfolding and Aggregation: The Relatedness between Parkinson's Disease and Hepatic Endoplasmic Reticulum Storage Disorders.
Topics: Afibrinogenemia; alpha 1-Antitrypsin; alpha 1-Antitrypsin Deficiency; alpha-Synuclein; Animals; Autophagy; Coagulants; Endoplasmic Reticulum; Fibrinogen; Gene Expression Regulation; Humans; Liver; Neuroprotective Agents; Parkinson Disease; Protease Inhibitors; Protein Aggregates; Protein Folding; Unfolded Protein Response | 2021 |
12 other study(ies) available for fibrinogen and Parkinson Disease
| Article | Year |
|---|---|
Fibrinogen and Complement Factor H Are Promising CSF Protein Biomarkers for Parkinson's Disease with Cognitive Impairment─A Proteomics-ELISA-Based Study.
Topics: Animals; Biomarkers; Cognition; Cognitive Dysfunction; Complement Factor H; Enzyme-Linked Immunosorbent Assay; Fibrinogen; Humans; Mice; Mice, Inbred C57BL; Neuropsychological Tests; Parkinson Disease; Proteomics | 2022 |
Brain proteome profiling implicates the complement and coagulation cascade in multiple system atrophy brain pathology.
Topics: Brain; Chromatography, Liquid; Cross-Sectional Studies; Disease Progression; Fibrinogen; Glial Fibrillary Acidic Protein; Humans; Multiple System Atrophy; Parkinson Disease; Parkinsonian Disorders; Proteome; Tandem Mass Spectrometry | 2022 |
Vascular, inflammatory and metabolic risk factors in relation to dementia in Parkinson's disease patients with type 2 diabetes mellitus.
Topics: Age Factors; Aged; Biomarkers; Blood Glucose; China; Cholesterol, LDL; Dementia; Diabetes Mellitus, Type 2; Female; Fibrinogen; Homocysteine; Humans; Hyperlipidemias; Inflammation; Male; Middle Aged; Parkinson Disease; Prognosis; Retrospective Studies; Risk Assessment; Risk Factors; Vascular Diseases | 2020 |
Tailor-made purified human platelet lysate concentrated in neurotrophins for treatment of Parkinson's disease.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Administration, Intranasal; Animals; Anti-Inflammatory Agents; Blood Cell Count; Blood Platelets; Cell Line; Diffusion; Fibrinogen; Hepacivirus; Humans; Lipopolysaccharides; Male; Mesencephalon; Mice, Inbred C57BL; Microglia; Neostriatum; Nerve Growth Factors; Neuroprotection; Neurotoxins; Parkinson Disease; Tyrosine 3-Monooxygenase | 2017 |
Is neuroinflammation involved in the development of dementia in patients with Parkinson's disease?
Topics: Aged; Aged, 80 and over; Biomarkers; C-Reactive Protein; Dementia; Female; Fibrinogen; Humans; Inflammation; Male; Parkinson Disease | 2013 |
Phenotypic profile of alternative activation marker CD163 is different in Alzheimer's and Parkinson's disease.
Topics: Aged; Aged, 80 and over; Alzheimer Disease; Amyloid beta-Peptides; Antigens, CD; Antigens, Differentiation, Myelomonocytic; Brain; Calcium-Binding Proteins; Cell Count; DNA-Binding Proteins; Female; Fibrinogen; Humans; Macrophages; Male; Membrane Glycoproteins; Microfilament Proteins; Microglia; Middle Aged; Neurologic Examination; Parkinson Disease; Plaque, Amyloid; Receptors, Cell Surface; Receptors, Immunologic | 2014 |
Specific changes of serum proteins in Parkinson's disease patients.
Topics: Apolipoproteins A; Biomarkers; Blood Proteins; Case-Control Studies; Female; Fibrinogen; Glycoproteins; Humans; Male; Middle Aged; Parkinson Disease; Proteinase Inhibitory Proteins, Secretory | 2014 |
Association of fibrinogen with Parkinson disease in elderly Japanese-American men: a prospective study.
Topics: Aged; Aged, 80 and over; Asian; Cohort Studies; Fibrinogen; Follow-Up Studies; Hawaii; Humans; Incidence; Japan; Logistic Models; Male; Multivariate Analysis; Odds Ratio; Parkinson Disease; Prevalence; Proportional Hazards Models; Prospective Studies; Risk Factors | 2010 |
Markers of inflammation in prevalent and incident Parkinson's disease in the Cardiovascular Health Study.
Topics: Aged; Aged, 80 and over; Albumins; Biomarkers; C-Reactive Protein; Enzyme-Linked Immunosorbent Assay; Female; Fibrinogen; Humans; Incidence; Inflammation; Interleukin-6; Leukocyte Count; Male; Parkinson Disease; Prevalence; Risk Factors; Tumor Necrosis Factor-alpha | 2012 |
Cerebrospinal fluid biomarkers of neuropathologically diagnosed Parkinson's disease subjects.
Topics: Aged; Aged, 80 and over; Apolipoprotein A-I; Apolipoproteins E; Biomarkers; Clusterin; Cohort Studies; Female; Fibrinogen; Glutathione S-Transferase pi; Humans; Male; Middle Aged; Parkinson Disease; Prealbumin; Protein Isoforms; Two-Dimensional Difference Gel Electrophoresis | 2012 |
Discovery and verification of panels of T-lymphocyte proteins as biomarkers of Parkinson's disease.
Topics: Biomarkers; Blotting, Western; Electrophoresis, Gel, Two-Dimensional; Fibrinogen; Humans; Parkinson Disease; Protein Isoforms; Proteome; T-Lymphocytes; Transaldolase | 2012 |
[On the effect of central nervous irritation on certain parameters of blood coagulation].
Topics: Age Factors; Animals; Blood Coagulation; Blood Coagulation Tests; Cerebral Ventriculography; Child; Epilepsy; Fibrinogen; Humans; Middle Aged; Parkinson Disease; Rabbits; Stereotaxic Techniques | 1968 |